• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4+CD25+调节性T细胞控制着硕大利什曼原虫的持续存在和免疫反应。

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

作者信息

Belkaid Yasmine, Piccirillo Ciriaco A, Mendez Susana, Shevach Ethan M, Sacks David L

机构信息

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Nature. 2002 Dec 5;420(6915):502-7. doi: 10.1038/nature01152.

DOI:10.1038/nature01152
PMID:12466842
Abstract

The long-term persistence of pathogens in a host that is also able to maintain strong resistance to reinfection, referred to as concomitant immunity, is a hallmark of certain infectious diseases, including tuberculosis and leishmaniasis. The ability of pathogens to establish latency in immune individuals often has severe consequences for disease reactivation. Here we show that the persistence of Leishmania major in the skin after healing in resistant C57BL/6 mice is controlled by an endogenous population of CD4+CD25+ regulatory T cells. These cells constitute 5-10% of peripheral CD4+ T cells in naive mice and humans, and suppress several potentially pathogenic responses in vivo, particularly T-cell responses directed against self-antigens. During infection by L. major, CD4+CD25+ T cells accumulate in the dermis, where they suppress-by both interleukin-10-dependent and interleukin-10-independent mechanisms-the ability of CD4+CD25- effector T cells to eliminate the parasite from the site. The sterilizing immunity achieved in mice with impaired IL-10 activity is followed by the loss of immunity to reinfection, indicating that the equilibrium established between effector and regulatory T cells in sites of chronic infection might reflect both parasite and host survival strategies.

摘要

病原体在宿主中长期持续存在,而宿主又能够维持对再感染的强大抵抗力,这种情况被称为伴随免疫,是包括结核病和利什曼病在内的某些传染病的一个标志。病原体在免疫个体中建立潜伏状态的能力通常会对疾病复发产生严重后果。在此,我们表明,在抗性C57BL/6小鼠愈合后,皮肤中硕大利什曼原虫的持续存在受内源性CD4+CD25+调节性T细胞群体控制。这些细胞在未接触过抗原的小鼠和人类外周CD4+T细胞中占5%-10%,并在体内抑制几种潜在的致病反应,特别是针对自身抗原的T细胞反应。在硕大利什曼原虫感染期间,CD4+CD25+T细胞在真皮中积聚,在那里它们通过依赖白细胞介素-10和不依赖白细胞介素-10的机制,抑制CD4+CD25-效应T细胞从该部位清除寄生虫的能力。白细胞介素-10活性受损的小鼠实现的无菌免疫之后是对再感染的免疫力丧失,这表明在慢性感染部位效应T细胞和调节性T细胞之间建立的平衡可能反映了寄生虫和宿主的生存策略。

相似文献

1
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.CD4+CD25+调节性T细胞控制着硕大利什曼原虫的持续存在和免疫反应。
Nature. 2002 Dec 5;420(6915):502-7. doi: 10.1038/nature01152.
2
Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity.CD4(+)CD25(+)调节性T细胞在持续性利什曼病再激活及伴随免疫控制中的作用。
J Exp Med. 2004 Jul 19;200(2):201-10. doi: 10.1084/jem.20040298.
3
Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunity.促凋亡的Bcl-2家族成员Bim促进持续性感染并限制保护性免疫。
Infect Immun. 2008 Mar;76(3):1179-85. doi: 10.1128/IAI.01093-06. Epub 2007 Dec 17.
4
CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.自然产生的CD4+调节性T细胞通过CCR5依赖的归巢作用至利什曼原虫主要感染部位,这有利于病原体持续存在。
J Exp Med. 2006 Oct 30;203(11):2451-60. doi: 10.1084/jem.20060956. Epub 2006 Oct 2.
5
The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.利什曼原虫主要种感染后早期的白细胞介素-4反应以及由此导致的辅助性T细胞2型(Th2)细胞成熟,从而促使BALB/c小鼠发生进行性疾病,这一过程受调节性CD4+CD25+ T细胞的控制。
J Immunol. 2002 Sep 15;169(6):3232-41. doi: 10.4049/jimmunol.169.6.3232.
6
Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.尽管感染部位的CD4+Foxp3+细胞有所增加,但BALB/c白细胞介素-4受体缺陷小鼠显示,在利什曼原虫主要易感性中,CD4+Foxp3阴性T细胞是白细胞介素-10的来源。
J Immunol. 2007 Aug 15;179(4):2435-44. doi: 10.4049/jimmunol.179.4.2435.
7
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.白细胞介素(IL)-10在愈合后皮肤中杜氏利什曼原虫持续存在中的作用以及抗IL-10受体抗体实现无菌治愈的治疗潜力。
J Exp Med. 2001 Nov 19;194(10):1497-506. doi: 10.1084/jem.194.10.1497.
8
Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection.影响用活生物体疫苗接种预防硕大利什曼原虫感染效果的条件。
Infect Immun. 2005 Aug;73(8):4714-22. doi: 10.1128/IAI.73.8.4714-4722.2005.
9
CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection.CD4+CD25+调节性T细胞在亚马逊利什曼原虫感染期间抑制致病性反应。
J Immunol. 2005 Jun 1;174(11):7147-53. doi: 10.4049/jimmunol.174.11.7147.
10
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.在用低剂量利什曼原虫主要亚种进行皮内攻击后,C57BL/6小鼠的初次免疫需要CD8 + T细胞。
J Immunol. 2002 Apr 15;168(8):3992-4000. doi: 10.4049/jimmunol.168.8.3992.

引用本文的文献

1
Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity.三级淋巴器官处于皮肤体液免疫的核心地位。
Immunol Rev. 2025 Sep;334(1):e70061. doi: 10.1111/imr.70061.
2
Mice mucosal leishmaniasis model shown high parasite load, increased cytotoxicity and impaired IL-10 T cell response.小鼠黏膜利什曼病模型显示出高寄生虫载量、细胞毒性增加和白细胞介素-10 T细胞反应受损。
Front Immunol. 2025 Aug 4;16:1621781. doi: 10.3389/fimmu.2025.1621781. eCollection 2025.
3
Tertiary lymphoid structures in pulmonary granulomas of cattle experimentally infected with aerosolized Mycobacterium bovis.
经气溶胶感染牛分枝杆菌的牛肺部肉芽肿中的三级淋巴结构
BMC Vet Res. 2025 Jun 5;21(1):403. doi: 10.1186/s12917-025-04804-x.
4
Improving reproducibility and translational potential of mouse models: lessons from studying leishmaniasis.提高小鼠模型的可重复性和转化潜力:利什曼病研究的经验教训。
Front Immunol. 2025 Apr 22;16:1559907. doi: 10.3389/fimmu.2025.1559907. eCollection 2025.
5
T cells augment self-tolerance during infection.T细胞在感染期间增强自身耐受性。
Nat Immunol. 2025 May;26(5):650-652. doi: 10.1038/s41590-025-02141-7.
6
The development and maintenance of immunity against visceral leishmaniasis.针对内脏利什曼病免疫力的发展与维持。
Front Immunol. 2024 Dec 9;15:1486407. doi: 10.3389/fimmu.2024.1486407. eCollection 2024.
7
PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression.过氧化物酶体增殖物激活受体δ通过限制II类主要组织相容性复合体反式激活因子的表达来抑制肿瘤内调节性T细胞的抑制功能。
bioRxiv. 2024 Dec 20:2024.12.16.628819. doi: 10.1101/2024.12.16.628819.
8
Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses.致病共生菌诱导的抑制性免疫印记阻碍T细胞疫苗反应。
Nat Commun. 2024 Dec 16;15(1):10335. doi: 10.1038/s41467-024-54644-w.
9
Skin autonomous antibody production regulates host-microbiota interactions.皮肤自主抗体产生调节宿主-微生物群相互作用。
Nature. 2025 Feb;638(8052):1043-1053. doi: 10.1038/s41586-024-08376-y. Epub 2024 Dec 11.
10
Dominant immune tolerance in the intestinal tract imposed by RelB-dependent migratory dendritic cells regulates protective type 2 immunity.依赖 RelB 的迁移树突状细胞在肠道中诱导的优势免疫耐受调节保护性 2 型免疫。
Nat Commun. 2024 Oct 23;15(1):9143. doi: 10.1038/s41467-024-53112-9.